1. [1] ICMR. Registry of colorectal cancer.
2. [2] Zlatian MO, Comanescu VM, Rosu FA, et al. Histochemical and immunohistochemical evidence of tumor heterogeneity in colorectal cancer. Rom J Morphol Embryol 2015;56(1):175-81.
3. [3] De Hertogh G, Gerboes PK. Practical and molecular evaluation of colorectal cancer: new roles for the pathologist in the era of targeted therapy. Arch Pathol Lab Med 2010;134(6):853-63.
4. Identification of clinically relevant molecular subtypes in colorectal cancer: the dawning of a new era;Johnston;The Oncol,2014
5. [5] Azarhoush R, Heidari K, Samadzadeh S, et al. Expression of p53 protein in colorectal cancer and association with prognostic factors in Northeast Iran. Acta Medica Iranica 2018;56(3):161-5.